{
    "symbol": "ONCY",
    "quarter": 4,
    "year": 2022,
    "date": "2023-03-03 11:40:02",
    "content": "  As a reminder, various remarks made during this call contain certain forward-looking statements relating to the company\u00e2\u0080\u0099s business prospects and the development and commercialization of pelareorep, including statements regarding the company\u00e2\u0080\u0099s focus, strategy and objectives, company\u00e2\u0080\u0099s belief as to the potential and mode of action of pelareorep as a cancer therapeutic, the design, aims and anticipated benefits of the company\u00e2\u0080\u0099s current pending clinical trials, and anticipated timing of the release of additional data, the company\u00e2\u0080\u0099s plans and expectations regarding potential registrational studies, company\u00e2\u0080\u0099s business development plans and strategies, company\u00e2\u0080\u0099s financial runway, and other statements related to anticipated developments in the company\u00e2\u0080\u0099s business."
}